Pneumonia, Ventilator-Associated Clinical Trial
Verified date | June 2007 |
Source | Cairo University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Egypt: Ministry of Health and Population |
Study type | Interventional |
Ventilator-associated pneumonia (VAP) is the leading cause of death among all nosocomial
infections in ventilated patients. Once intubated, the risk of pneumonia in hospitalized
patients is increased 3-10 fold; almost 90% of hospital-acquired pneumonia occurs in
intubated patients. Each episode of VAP is associated with 7-9 days of additional hospital
stay with an estimated increase in cost of care that exceeds $40,000. In an effort to
control VAP, several studies were conducted including oral and gastric decontamination with
antibiotics, rotation of the bed, and local instillation of antibiotics via endotracheal
tube. Despite such efforts, VAP is still a major complication for intubated patients.
The effect of gravity on bacterial colonization of the endotracheal tube was recently
explored in an animal study that was conducted at the United States National Institutes of
Health. The study demonstrated a significantly lower tracheal colonization and decreased
alveolar contamination in ventilated sheep when positioned on their side allowing for
tracheal drainage by gravity. Such findings have not been validated in clinical practice and
the need for clinical trials studying the effect of lateral positioning have been demanded.
Therefore, we aimed our randomized controlled trial to test the hypothesis that intubated
infants who are positioned on their side are at lower risk for contracting microbes in their
trachea when compared to those in a supine position.
Status | Completed |
Enrollment | 60 |
Est. completion date | July 2006 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A to 48 Hours |
Eligibility |
Inclusion Criteria: - Term and premature infants >28 weeks of gestation - Postnatal age <48 hours - Mechanical ventilation >5 days Exclusion Criteria: - Congenital infections - Congenital pneumonia - Congenital anomalies such as tracheal-esophageal fistula, thoracic cage deformities and diaphragmatic hernia - not maintained on mechanical ventilation for 5 complete days |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of colonization in tracheal aspirates at 2 days | 2 days | ||
Secondary | Number of colonies in colonized infants | 5 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06370598 -
Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia
|
Phase 1/Phase 2 | |
Terminated |
NCT02806141 -
Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates
|
Phase 3 | |
Completed |
NCT01765530 -
Efficacy Study of a Novel Device to Clean the Endotracheal Tube
|
N/A | |
Completed |
NCT00521677 -
Comparison Between Two Methods of Oral Care on the Incidence of VAP
|
N/A | |
Completed |
NCT00529776 -
Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation Therapy
|
N/A | |
Completed |
NCT03401463 -
Assesment of the Endotracheal Tube Cuff Pressure Values in ICU Pateints Before and After Training Seminar
|
N/A | |
Completed |
NCT02950519 -
Endotracheal Tube Cuff Pressures in Ventilated Patients
|
N/A | |
Completed |
NCT01875692 -
Can we Better Understand the Development of VAP and Eventually Predict and Prevent it?
|
N/A | |
Completed |
NCT00515034 -
A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
|
Phase 2 | |
Recruiting |
NCT05117125 -
Biomarkers for Ventilator-associated Pneumonia
|
||
Completed |
NCT04755972 -
Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2
|
N/A | |
Terminated |
NCT02940626 -
Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.
|
Phase 2 | |
Completed |
NCT01577862 -
Colistin and Rifampicin for MDR-Acinetobacter
|
Phase 3 | |
Completed |
NCT00572559 -
Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus
|
Phase 4 | |
Withdrawn |
NCT04566172 -
Preoperative Optimization to Improve Functional Status
|
N/A | |
Recruiting |
NCT04215692 -
Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients
|
N/A | |
Completed |
NCT03816956 -
Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
|
Phase 3 | |
Active, not recruiting |
NCT01123681 -
Intubation and Extubation Over 48 Hours Mechanical Ventilation
|
N/A | |
Recruiting |
NCT04839653 -
Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria
|
N/A | |
Recruiting |
NCT03527992 -
Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia
|
N/A |